Recent Advances in the Development of Hybrid Drugs
- PMID: 39065586
- PMCID: PMC11279447
- DOI: 10.3390/pharmaceutics16070889
Recent Advances in the Development of Hybrid Drugs
Abstract
In the search for innovative, selective, effective, and safer treatment strategies, hybrid drugs have gained worldwide momentum [...].
Conflict of interest statement
The author declares no conflicts of interest.
References
-
- Chen Y., Zhao T., Bai M., Gu T., Sun J., He Z., Zhang S., Luo C. Emerging Small Molecule-Engineered Hybrid Nanomedicines for Cancer Therapy. Chem. Eng. J. 2022;435:135160. doi: 10.1016/J.CEJ.2022.135160. - DOI
Publication types
LinkOut - more resources
Full Text Sources
